Industry Session
The Program is Preliminary and is a subject to change.
Chair: Quentin Anstee, Newcastle University, UK
12:40 - 13:00
Apollo Endosurgery - Endoscopic Bariatric Therapies and NAFLD/NASH patients: do we have a game changer?
Jörn Schattenberg, University Medical Center Mainz, Germany
13:00 - 13:20
Pandorum Technologies - Stem-cell derived Exosome treatment reverses NASH: A proof of concept study using human liver organoid system
Wenson David Rajan, Pandorm Technolgies.Pvt. Ltd, India
